2022-12-08: With the advent of the post-epidemic era, the demand for drugs related to the treatment of colds is rising, and even the news of drug outlets such as Qinghua Qingyuan, ibupro And in Chinese medicine, the most attention is still Lianhua Qinglu, the drug manufacturer is Yiling Pharmaceutical (002603.SZ).
12+ search results for 'Apac'.
2022-12-08: Journalist. Yu Rong Wu Editor.. Gaga Hanxiang On November 30, multiple districts in Guangzhou issued notices on optimizing and improving epidemic prevention and control measures. Subsequently, several districts announced the lifting of the epidemic prevention and control temporary control area and the
2022-12-07: Beijing Daily client. Cao Yu. Journalist. Luo Jing. Mei editor. Yuan Li On December 7, the third term of winter - heavy snow - began. Heavy snow marks the official start of the mid-winter season, when temperatures drop significantly, precipitation increases, and there will be significant cooling in northern
2022-12-06: the relevant person in charge of Yiling Pharmaceutical told the media that Yiling Pharmaceutical has been doing a series of work to improve production capacity in the past two years. It also said that the production plan of Yiling Pharmaceutical is "production by sale," and can adjust the production
2022-12-07: Beijing Daily client. Yao. Journalist. Bai Bo The COVID-19 pandemic has had a huge impact on human health and socio-economic development. At present, the Omicron mutant strain is mainly prevalent, its toxicity is reduced, but more contagious, resulting in an increase in the number of people with the
2022-12-06: Citizens outside Zhengjia Plaza Shopping Center, Guangzhou, Guangdong Province, December 3, 2022. At present, Guangzhou all walks of life orderly resumption of work, Guangzhou Tianhe business circle passenger flow orderly recovery. Recently, the topic of the toxicity of the Omicron mutant strain of
2022-12-07: In the follow-up epidemic prevention and control process, we need to focus not only on prevention and control policy changes and infection risk assessment, but also on how to divert patients, improve health care capacity and emergency preparedness. Under current policy, the latter is perhaps even more
2022-12-07: China Times (www.chinatimes.net.cn) journalist. Guo Yilin. Yu Na. Beijing reporting Recently, around the "four types of drugs" purchase policy adjustment, the country blew a tide of "medicine." In the face of the price rise brought by "antimony medicine," many regulators have issued a warning. Many
2022-12-07: Although the pathogenicity of the Omitrazole mutant has decreased significantly, its transmission capacity has increased significantly, with potential impacts on social functioning and basic health services as a result of short periods of high levels of infection among those providing for the proper
2022-12-06: Normalized nucleic acids are saying goodbye. In recent days, China has made many adjustments to the prevention and control measures of the new coronavirus epidemic, including arrangements for nucleic acid testing, since most no longer check the negative proof of nucleic acid testing, "non-necessary
2022-12-07: The United States does not review the reasons for its backwardness, but uses Taiwan's security risk as a reason to request TSMC to transfer talent and production capacity to the United States. Faced with the TSMC problem, the DPP authorities should strengthen talent and R & D policies on the one hand,
2022-12-06: with a total detection capacity of 45.55 million doses / day. To date, there have been 11.5 billion completed nucleic acid tests nationwide. This means that more than 1.4 billion Chinese people, on average, have done nucleotides nine times each. Behind such large amounts of nucleic acid testing is
Load More
12+ search results for 'Apac'.
2022-12-08: With the advent of the post-epidemic era, the demand for drugs related to the treatment of colds is rising, and even the news of drug outlets such as Qinghua Qingyuan, ibupro And in Chinese medicine, the most attention is still Lianhua Qinglu, the drug manufacturer is Yiling Pharmaceutical (002603.SZ).
TOUTIAO
2 months ago
1 minute read
2022-12-08: Journalist. Yu Rong Wu Editor.. Gaga Hanxiang On November 30, multiple districts in Guangzhou issued notices on optimizing and improving epidemic prevention and control measures. Subsequently, several districts announced the lifting of the epidemic prevention and control temporary control area and the
TOUTIAO
2 months ago
1 minute read
2022-12-07: Beijing Daily client. Cao Yu. Journalist. Luo Jing. Mei editor. Yuan Li On December 7, the third term of winter - heavy snow - began. Heavy snow marks the official start of the mid-winter season, when temperatures drop significantly, precipitation increases, and there will be significant cooling in northern
TOUTIAO
2 months ago
1 minute read
Lianhua's "Qingwen" or not "Qingwen" Yiling Pharmaceutical has the final say-PR Newswire APAC
2022-12-06: the relevant person in charge of Yiling Pharmaceutical told the media that Yiling Pharmaceutical has been doing a series of work to improve production capacity in the past two years. It also said that the production plan of Yiling Pharmaceutical is "production by sale," and can adjust the production
TOUTIAO
2 months ago
1 minute read
2022-12-07: Beijing Daily client. Yao. Journalist. Bai Bo The COVID-19 pandemic has had a huge impact on human health and socio-economic development. At present, the Omicron mutant strain is mainly prevalent, its toxicity is reduced, but more contagious, resulting in an increase in the number of people with the
TOUTIAO
2 months ago
4 minutes read
2022-12-06: Citizens outside Zhengjia Plaza Shopping Center, Guangzhou, Guangdong Province, December 3, 2022. At present, Guangzhou all walks of life orderly resumption of work, Guangzhou Tianhe business circle passenger flow orderly recovery. Recently, the topic of the toxicity of the Omicron mutant strain of
TOUTIAO
2 months ago
1 minute read
2022-12-07: In the follow-up epidemic prevention and control process, we need to focus not only on prevention and control policy changes and infection risk assessment, but also on how to divert patients, improve health care capacity and emergency preparedness. Under current policy, the latter is perhaps even more
TOUTIAO
2 months ago
2 minutes read
2022-12-07: China Times (www.chinatimes.net.cn) journalist. Guo Yilin. Yu Na. Beijing reporting Recently, around the "four types of drugs" purchase policy adjustment, the country blew a tide of "medicine." In the face of the price rise brought by "antimony medicine," many regulators have issued a warning. Many
TOUTIAO
2 months ago
3 minutes read
2022-12-07: Although the pathogenicity of the Omitrazole mutant has decreased significantly, its transmission capacity has increased significantly, with potential impacts on social functioning and basic health services as a result of short periods of high levels of infection among those providing for the proper
TOUTIAO
2 months ago
3 minutes read
2022-12-06: Normalized nucleic acids are saying goodbye. In recent days, China has made many adjustments to the prevention and control measures of the new coronavirus epidemic, including arrangements for nucleic acid testing, since most no longer check the negative proof of nucleic acid testing, "non-necessary
TOUTIAO
2 months ago
1 minute read
2022-12-07: The United States does not review the reasons for its backwardness, but uses Taiwan's security risk as a reason to request TSMC to transfer talent and production capacity to the United States. Faced with the TSMC problem, the DPP authorities should strengthen talent and R & D policies on the one hand,
TOUTIAO
2 months ago
1 minute read
2022-12-06: with a total detection capacity of 45.55 million doses / day. To date, there have been 11.5 billion completed nucleic acid tests nationwide. This means that more than 1.4 billion Chinese people, on average, have done nucleotides nine times each. Behind such large amounts of nucleic acid testing is
TOUTIAO
2 months ago
1 minute read